Repligen (RGEN) Amortization of Deferred Charges (2021 - 2026)
Repligen (RGEN) posted quarterly Amortization of Deferred Charges of $4.7 million for Q2 2026, up 0.55% year-over-year from $4.7 million in Q2 2025, and down 1.34% quarter-over-quarter from $4.8 million in Q1 2026.
Repligen (RGEN) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Repligen (RGEN) has reported Amortization of Deferred Charges for 6 consecutive years, with $4.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Amortization of Deferred Charges rose 0.55% year-over-year to $4.7 million; the TTM figure through Jun 2026 stood at $18.5 million (down 37.18% YoY), while the FY2025 annual figure was $18.2 million, up 7.83% from the prior year.
- Amortization of Deferred Charges retreated to $4.7 million in Q2 2026 per RGEN's latest filing, from $4.8 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $16.2 million in Q4 2023 and bottomed at -$1.4 million in Q4 2022.
- Historically, Amortization of Deferred Charges has averaged $3.3 million across 5 years, with a median of $4.1 million in 2024.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges sank 619.08% — and 2023, when it jumped 1290.07%.
- Repligen's Amortization of Deferred Charges stood at -$1.4 million in 2022, then surged by 1290.07% to $16.2 million in 2023, then sank by 74.42% to $4.1 million in 2024, then rose by 12.1% to $4.6 million in 2025, then grew by 1.51% to $4.7 million in 2026.
- Business Quant data shows RGEN's Amortization of Deferred Charges at $4.7 million in Q2 2026, $4.8 million in Q1 2026, and $4.6 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.71 Mn |
| Jun 30, 2026 | 4.71 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 4.40 Mn |
| Sep 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 4.69 Mn |
| Jun 30, 2025 | 4.69 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.14 Mn |
| Dec 31, 2024 | 4.14 Mn |
| Dec 31, 2023 | 16.19 Mn |
| Dec 31, 2023 | 16.19 Mn |
| Sep 30, 2023 | 459,000.00 |
| Sep 30, 2023 | 459,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Jun 30, 2023 | 457,000.00 |